Published in J Med Virol on April 01, 2002
Validation of laboratory-developed molecular assays for infectious diseases. Clin Microbiol Rev (2010) 2.72
Measurement of human cytomegalovirus loads by quantitative real-time PCR for monitoring clinical intervention in transplant recipients. J Clin Microbiol (2003) 1.64
Comparison of automated and manual nucleic acid extraction methods for detection of enterovirus RNA. J Clin Microbiol (2003) 1.56
Simultaneous quantification of Epstein-Barr virus, cytomegalovirus, and human herpesvirus 6 DNA in samples from transplant recipients by multiplex real-time PCR assay. J Clin Microbiol (2007) 1.08
Detection of Kaposi sarcoma associated herpesvirus in peripheral blood of HIV-infected individuals and progression to Kaposi's sarcoma. Lancet (1995) 10.63
Infusions of donor leukocytes to treat Epstein-Barr virus-associated lymphoproliferative disorders after allogeneic bone marrow transplantation. N Engl J Med (1994) 5.28
Myostatin, a negative regulator of muscle growth, functions by inhibiting myoblast proliferation. J Biol Chem (2000) 3.46
Hybridization of bird species. Science (1992) 2.91
Intense Natural Selection in a Population of Darwin's Finches (Geospizinae) in the Galapagos. Science (1981) 2.71
Acute meningoencephalitis and meningitis due to primary HIV infection. BMJ (2002) 2.52
Hepatitis C virus: evidence for sexual transmission. BMJ (1991) 2.50
Phylogeny of Darwin's finches as revealed by mtDNA sequences. Proc Natl Acad Sci U S A (1999) 2.42
The methodology and operation of a pilot randomized control trial of the effectiveness of the Bug Busting method against a single application insecticide product for head louse treatment. Public Health (2000) 2.38
Biological characterization and clinical applications of a monoclonal antibody recognizing an antigen restricted to neuroectodermal tissues. Int J Cancer (1983) 2.36
Detection of human herpesvirus 8 DNA in semen from HIV-infected individuals but not healthy semen donors. AIDS (1997) 2.20
Prevalence of antibodies to human T cell leukaemia/lymphoma virus in blood donors in north London. BMJ (1993) 2.07
Fatal microcystin intoxication in haemodialysis unit in Caruaru, Brazil. Lancet (1998) 2.06
Allogeneic hematopoietic stem cell transplantation and norovirus gastroenteritis: a previously unrecognized cause of morbidity. Clin Infect Dis (2009) 2.04
Mice lacking desmocollin 1 show epidermal fragility accompanied by barrier defects and abnormal differentiation. J Cell Biol (2001) 2.01
Establishment of complete and mixed donor chimerism after allogeneic lymphohematopoietic transplantation: recommendations from a workshop at the 2001 Tandem Meetings of the International Bone Marrow Transplant Registry and the American Society of Blood and Marrow Transplantation. Biol Blood Marrow Transplant (2001) 2.00
Molecular identification of a novel retrovirus repeatedly isolated from patients with multiple sclerosis. The Collaborative Research Group on Multiple Sclerosis. Proc Natl Acad Sci U S A (1997) 1.97
In vivo CAMPATH-1H prevents graft-versus-host disease following nonmyeloablative stem cell transplantation. Blood (2000) 1.93
Ecological Character Displacement in Darwin's Finches. Science (1985) 1.91
Monoclonal antibodies against human T lymphocytes label Purkinje neurones of many species. Nature (1982) 1.85
Bill size, body size, and the ecological adaptations of bird species to competitive situations on islands. Syst Zool (1968) 1.81
Comparative landscape genetics and the adaptive radiation of Darwin's finches: the role of peripheral isolation. Mol Ecol (2005) 1.81
Primary cytomegalovirus infection in an outpatient setting--laboratory markers and clinical aspects. Infection (2003) 1.78
Improvement of HCV genome detection with "short" PCR products. Lancet (1991) 1.76
HIV-1 RNA serum-load and resistant viral genotypes during early zidovudine therapy. Lancet (1995) 1.67
A monoclonal antibody against neurofilament protein specifically labels a subpopulation of rat sensory neurones. J Comp Neurol (1984) 1.63
Detection of virion-associated MSRV-RNA in serum of patients with multiple sclerosis. Lancet (1998) 1.61
Real-time PCR quantitation of hepatitis B virus DNA using automated sample preparation and murine cytomegalovirus internal control. J Virol Methods (2005) 1.57
Detection of serum reverse transcriptase activity in patients with ALS and unaffected blood relatives. Neurology (2005) 1.57
Mobile phones in clinical practice: reducing the risk of bacterial contamination. Int J Clin Pract (2014) 1.52
Amniotic membrane collagen content and type distribution in women with preterm premature rupture of the membranes in pregnancy. Br J Obstet Gynaecol (1997) 1.51
On the origin of Darwin's finches. Mol Biol Evol (2001) 1.46
Heritability of morphological traits in Darwin's finches: misidentified paternity and maternal effects. Heredity (Edinb) (2001) 1.46
Skinfold thickness measurements in obese subjects. Am J Clin Nutr (1990) 1.45
Hepatitis C antibody profile and viraemia prevalence in adults with severe haemophilia. Br J Haematol (1991) 1.42
Enhanced detection by PCR of hepatitis C virus RNA. Lancet (1990) 1.35
Exploiting CTLA-4, PD-1 and PD-L1 to reactivate the host immune response against cancer. Br J Cancer (2013) 1.32
Novel non-isotopic in situ hybridization technique detects small (1 Kb) unique sequences in routinely G-banded human chromosomes: fine mapping of N-myc and beta-NGF genes. Nucleic Acids Res (1987) 1.30
Diverging effects of HLA-DPB1 matching status on outcome following unrelated donor transplantation depending on disease stage and the degree of matching for other HLA alleles. Leukemia (2009) 1.29
Pitfalls with rapid HIV antibody testing in HIV-infected children in the Western Cape, South Africa. J Clin Virol (2006) 1.29
Pooling strategies to reduce the cost of HIV-1 RNA load monitoring in a resource-limited setting. Clin Infect Dis (2011) 1.28
Detection of herpesvirus DNA by nested polymerase chain reaction in cerebrospinal fluid of human immunodeficiency virus-infected persons with neurologic disease: a prospective evaluation. J Infect Dis (1995) 1.27
Effects of handling and storage of blood on the stability of hepatitis C virus RNA: implications for NAT testing in transfusion practice. Vox Sang (2000) 1.27
Darwin's finches: population variation and natural selection. Proc Natl Acad Sci U S A (1976) 1.27
Recurrent patterns of natural selection in a population of Darwin's finches. Nature (1984) 1.26
Zidovudine with nevirapine for the prevention of HIV mother-to-child transmission reduces nevirapine resistance in mothers from the Western Cape, South Africa. J Med Virol (2008) 1.23
Cross-reactivity in flavivirus serology: new implications of an old finding? Med Microbiol Immunol (2002) 1.21
Evaluation of 11 enzyme immunoassays for the detection of immunoglobulin M antibodies to Epstein-Barr virus. J Virol Methods (1996) 1.20
Development and evaluation of a real-time RT-PCR assay for quantification of cell-free human immunodeficiency virus type 2 using a Brome Mosaic Virus internal control. J Virol Methods (2006) 1.20
Ecological character displacement. Science (1994) 1.20
Prolonged Th2 cell activation and increased viral replication in HIV-Leishmania co-infected patients despite treatment. Trans R Soc Trop Med Hyg (1996) 1.19
Probiotics for induction of remission in ulcerative colitis. Cochrane Database Syst Rev (2007) 1.19
Identification of a mutation in the low density lipoprotein receptor gene associated with recessive familial hypercholesterolemia in swine. Am J Med Genet (1998) 1.15
Evaluation of the reliability of 6 current anti-HIV-1/HIV-2 enzyme immunoassays. J Virol Methods (1995) 1.14
Superiority of reduced-intensity allogeneic transplantation over conventional treatment for relapse of Hodgkin's lymphoma following autologous stem cell transplantation. Bone Marrow Transplant (2008) 1.14
Quantification of reverse transcriptase in ALS and elimination of a novel retroviral candidate. Neurology (2008) 1.12
Evaluation of diagnostic methods for the detection of cytomegalovirus in recipients of allogeneic stem cell transplants. J Clin Virol (2001) 1.09
Stability and inactivation of SARS coronavirus. Med Microbiol Immunol (2005) 1.09
Diphtheria immunity in health staff. Lancet (1996) 1.08
The role of viral load determination for the management of human immunodeficiency virus, hepatitis B virus and hepatitis C virus infection. J Clin Virol (2001) 1.08
Specific human cellular immunity to bcr-abl oncogene-derived peptides. Blood (1996) 1.08
Detection of varicella-zoster virus DNA using the polymerase chain reaction in an immunocompromised patient with transverse myelitis secondary to herpes zoster. Genitourin Med (1993) 1.08
Outcome of second allogeneic transplants using reduced-intensity conditioning following relapse of haematological malignancy after an initial allogeneic transplant. Bone Marrow Transplant (2008) 1.08
A second autologous transplant may be efficacious in selected patients with Hodgkin's lymphoma relapsing after a previous autograft. Leuk Lymphoma (2007) 1.08
Differential diagnosis of HTLV-I and HTLV-II infections by restriction enzyme analysis of 'nested' PCR products. J Virol Methods (1992) 1.07
Viral zoonoses - a threat under control? Intervirology (2003) 1.07
Use of BMI in the assessment of undernutrition in older subjects: reflecting on practice. Proc Nutr Soc (2005) 1.04
Diverse HIV-1 genetic subtypes in UK. Lancet (1996) 1.04
Laboratory diagnosis of norovirus: which method is the best? Intervirology (2003) 1.04
Induction of cytomegalovirus (CMV)-specific T-cell responses using dendritic cells pulsed with CMV antigen: a novel culture system free of live CMV virions. Blood (2001) 1.03
Prediction of graft versus host disease by frequency analysis of cytotoxic T cells after unrelated donor bone marrow transplantation. Transplantation (1989) 1.03
Neutral locus heterozygosity, inbreeding, and survival in Darwin's ground finches (Geospiza fortis and G. scandens). Heredity (Edinb) (2004) 1.03
Variety of interpretation systems for human immunodeficiency virus type 1 genotyping: confirmatory information or additional confusion? Curr Drug Targets Infect Disord (2003) 1.03
The effects of urethritis on seminal plasma HIV-1 RNA loads in homosexual men not receiving antiretroviral therapy. Sex Transm Infect (2005) 1.03
Seroprevalence of herpes simplex virus types 1 and type 2 in the Frankfurt am Main area, Germany. Med Microbiol Immunol (2002) 1.02
Combination therapy with interferon alpha and ribavirin for chronic hepatitis C virus infection in thalassaemic patients. Br J Haematol (1997) 1.02
Moving Canadian governmental policies beyond a focus on individual lifestyle: some insights from complexity and critical theories. Health Promot Int (2010) 1.02
Running focus groups with elderly and disabled elderly participants. Appl Ergon (2000) 1.02
Effect of alpha-interferon therapy on hepatitis C viraemia in community-acquired chronic non-A, non-B hepatitis: a quantitative polymerase chain reaction study. J Med Virol (1991) 1.02
Use of monoclonal antibody panel to identify malignant cells in cerebrospinal fluid. Lancet (1984) 1.01
Monoclonal antibody UJ 127:11 detects a 220,000-240,000 kdal. glycoprotein present on a sub-set of neuroectodermally derived cells. Int J Cancer (1983) 1.01
The effects of early syphilis on CD4 counts and HIV-1 RNA viral loads in blood and semen. Sex Transm Infect (2005) 0.99
Lifestyle factors affecting fruit and vegetable consumption in the UK Women's Cohort Study. Appetite (2001) 0.98
Comparison of magnetic resonance imaging with neuropathological findings in the diagnosis of HIV and CMV associated CNS disease in AIDS. J Neurol Neurosurg Psychiatry (1997) 0.98
Chronic liver disease due to hepatitis C. BMJ (1993) 0.98
Outbreaks of infectious diseases in stem cell transplant units: a silent cause of death for patients and transplant programmes. Bone Marrow Transplant (2004) 0.98
Immunohistological diagnosis of central nervous system tumours using a monoclonal antibody panel. J Clin Pathol (1985) 0.98
Magnetic resonance imaging, thallium-201 SPET scanning, and laboratory analyses for discrimination of cerebral lymphoma and toxoplasmosis in AIDS. Sex Transm Infect (1998) 0.95
Comparison of commercial assays for the quantification of HBV DNA load in health care workers: calibration differences. J Virol Methods (2002) 0.95
N-myc amplification in malignant astrocytoma. Lancet (1985) 0.95
Typing of human papillomaviruses in cervical carcinoma biopsies from Cape Town. J Med Virol (1994) 0.94
Reproductive compatibility of voles from separate continents (Mammalia: Clethrionomys). J Zool (1974) 0.94
Infection of cultured intestinal epithelial cells with severe acute respiratory syndrome coronavirus. Cell Mol Life Sci (2004) 0.93